Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
By Indication (Type-2 Diabetes, Obesity/Weight Management, and Other Emerging Indications): The type 2 diabetes segment is projected to reach USD 169.62 billion by 2033, supported by rising global diabetes prevalence, established clinical efficacy of GLP-1 therapies, and continued physician preference for managing blood glucose and metabolic risks
Methods: In this study, we established a C57BL/6J male mouse model by orally administering Porphyromonas gingivalis ( P
fda, cder
Any claims or articles that are placed are for entertainment and educational purposes only
Jang HJ, Ridgeway SD, Kim JA
How to proceed an order
US$ 23.35
US$ 28.36
US$ 27.08
US$ 25.05
US$ 25.65
